129 related articles for article (PubMed ID: 23109358)
1. Receptor-based virtual screening and biological characterization of human apurinic/apyrimidinic endonuclease (Ape1) inhibitors.
Ruiz FM; Francis SM; Tintoré M; Ferreira R; Gil-Redondo R; Morreale A; Ortiz ÁR; Eritja R; Fàbrega C
ChemMedChem; 2012 Dec; 7(12):2168-78. PubMed ID: 23109358
[TBL] [Abstract][Full Text] [Related]
2. Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors.
Zawahir Z; Dayam R; Deng J; Pereira C; Neamati N
J Med Chem; 2009 Jan; 52(1):20-32. PubMed ID: 19072053
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of 3-carbamoylbenzoic acid derivatives as inhibitors of human apurinic/apyrimidinic endonuclease 1 (APE1).
Aiello F; Shabaik Y; Esqueda A; Sanchez TW; Grande F; Garofalo A; Neamati N
ChemMedChem; 2012 Oct; 7(10):1825-39. PubMed ID: 22952012
[TBL] [Abstract][Full Text] [Related]
4. Isolation of a small molecule inhibitor of DNA base excision repair.
Madhusudan S; Smart F; Shrimpton P; Parsons JL; Gardiner L; Houlbrook S; Talbot DC; Hammonds T; Freemont PA; Sternberg MJ; Dianov GL; Hickson ID
Nucleic Acids Res; 2005; 33(15):4711-24. PubMed ID: 16113242
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule inhibitors of APE1 DNA repair function: an overview.
Al-Safi RI; Odde S; Shabaik Y; Neamati N
Curr Mol Pharmacol; 2012 Jan; 5(1):14-35. PubMed ID: 22122462
[TBL] [Abstract][Full Text] [Related]
6. Structure-based virtual screening toward the discovery of novel inhibitors of the DNA repair activity of the human apurinic/apyrimidinic endonuclease 1.
Guerreiro PS; Estácio SG; Antunes F; Fernandes AS; Pinheiro PF; Costa JG; Castro M; Miranda JP; Guedes RC; Oliveira NG
Chem Biol Drug Des; 2016 Dec; 88(6):915-925. PubMed ID: 27450574
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
Luo M; Kelley MR
Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
[TBL] [Abstract][Full Text] [Related]
9. New oligonucleotide derivatives as unreactive substrate analogues and potential inhibitors of human apurinic/apyrimidinic endonuclease APE1.
Kuznetsov NA; Kupryushkin MS; Abramova TV; Kuznetsova AA; Miroshnikova AD; Stetsenko DA; Pyshnyi DV; Fedorova OS
Mol Biosyst; 2016 Jan; 12(1):67-75. PubMed ID: 26548492
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Macrocyclic Inhibitors of Apurinic/Apyrimidinic Endonuclease 1.
Trilles R; Beglov D; Chen Q; He H; Wireman R; Reed A; Chennamadhavuni S; Panek JS; Brown LE; Vajda S; Porco JA; Kelley MR; Georgiadis MM
J Med Chem; 2019 Feb; 62(4):1971-1988. PubMed ID: 30653918
[TBL] [Abstract][Full Text] [Related]
11. Diverse small molecule inhibitors of human apurinic/apyrimidinic endonuclease APE1 identified from a screen of a large public collection.
Dorjsuren D; Kim D; Vyjayanti VN; Maloney DJ; Jadhav A; Wilson DM; Simeonov A
PLoS One; 2012; 7(10):e47974. PubMed ID: 23110144
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of human apurinic/apyrimidinic endonuclease-1 inhibitors.
Srinivasan A; Wang L; Cline CJ; Xie Z; Sobol RW; Xie XQ; Gold B
Biochemistry; 2012 Aug; 51(31):6246-59. PubMed ID: 22788932
[TBL] [Abstract][Full Text] [Related]
13. Efficient inhibition of human AP endonuclease 1 (APE1) via substrate masking by abasic site-binding macrocyclic ligands.
Kotera N; Poyer F; Granzhan A; Teulade-Fichou MP
Chem Commun (Camb); 2015 Nov; 51(88):15948-51. PubMed ID: 26377038
[TBL] [Abstract][Full Text] [Related]
14. Novel small-molecule inhibitor of apurinic/apyrimidinic endonuclease 1 blocks proliferation and reduces viability of glioblastoma cells.
Bapat A; Glass LS; Luo M; Fishel ML; Long EC; Georgiadis MM; Kelley MR
J Pharmacol Exp Ther; 2010 Sep; 334(3):988-98. PubMed ID: 20504914
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties.
Poletto M; Malfatti MC; Dorjsuren D; Scognamiglio PL; Marasco D; Vascotto C; Jadhav A; Maloney DJ; Wilson DM; Simeonov A; Tell G
Mol Carcinog; 2016 May; 55(5):688-704. PubMed ID: 25865359
[TBL] [Abstract][Full Text] [Related]
16. A dominant-negative form of the major human abasic endonuclease enhances cellular sensitivity to laboratory and clinical DNA-damaging agents.
McNeill DR; Wilson DM
Mol Cancer Res; 2007 Jan; 5(1):61-70. PubMed ID: 17259346
[TBL] [Abstract][Full Text] [Related]
17. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
Bobola MS; Finn LS; Ellenbogen RG; Geyer JR; Berger MS; Braga JM; Meade EH; Gross ME; Silber JR
Clin Cancer Res; 2005 Oct; 11(20):7405-14. PubMed ID: 16243814
[TBL] [Abstract][Full Text] [Related]
18. Vector-based Ape1 small interfering RNA enhances the sensitivity of human osteosarcoma cells to endostatin in vivo.
Wang D; Zhong ZY; Li MX; Xiang DB; Li ZP
Cancer Sci; 2007 Dec; 98(12):1993-2001. PubMed ID: 17892509
[TBL] [Abstract][Full Text] [Related]
19. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
[TBL] [Abstract][Full Text] [Related]
20. Nm23-H1 protein binds to APE1 at AP sites and stimulates AP endonuclease activity following ionizing radiation of the human lung cancer A549 cells.
Zhang ZM; Yang XQ; Wang D; Wang G; Yang ZZ; Qing Y; Yang ZX; Li MX; Xiang DB
Cell Biochem Biophys; 2011 Dec; 61(3):561-72. PubMed ID: 21769563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
